Unlike other epithelial cancer types, circulating tumor cells (CTCs) are less frequently
detected in the peripheral blood of non–small cell lung cancer (NSCLC) patients using …

Malignant pleural mesothelioma is a particularly aggressive and locally invasive malignancy
with a poor prognosis despite advances in understanding of cancer cell biology and …

Background Octamer-binding transcription factor 4 (Oct-4) has been identified to participate
in the tumorigenicity and malignancy of non-small cell lung cancer (NSCLC). However, its …

Purpose Malignant pleural effusions (MPEs) are often observed in lung cancer, particularly
adenocarcinoma. The aim of this study was to investigate epidermal growth factor receptor …

Malignant pleural effusions (MPEs) are a common manifestation found in patients with lung
cancer. After cytological and histological confirmation of malignancy, talc pleurodesis still …

Background. The data on expression and clinical impact of cancer stem cell markers SOX2,
NANOG and OCT4 in lung cancer is still lacking. The aim of our study was to compare …

Background To investigate the survival prognostic value of the radiomic features of 18F-FDG
PET in patients who had EGFR (epidermal growth factor receptor) mutated lung …

Tumor metastasis involves the migration of cells from primary site to a distant location.
Recently, it was established that cancer cells from the same tumor were heterogeneous in …

Lung cancer is the major cause of cancer related lethality worldwide, and metastasis to
distant organs is the pivotal cause of death for the vast majority of lung cancer patients …

Malignant pleural effusion (PE) and ascites, common clinical manifestations in advanced
cancer patients, are associated with a poor prognosis. However, the biological …